Mackenzie Financial Corp Acquires 171,200 Shares of Tilray Inc (NASDAQ:TLRY)

Mackenzie Financial Corp boosted its stake in Tilray Inc (NASDAQ:TLRY) by 482.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 206,659 shares of the company’s stock after purchasing an additional 171,200 shares during the period. Mackenzie Financial Corp’s holdings in Tilray were worth $477,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of the stock. Hudson Bay Capital Management LP increased its stake in shares of Tilray by 29.4% in the third quarter. Hudson Bay Capital Management LP now owns 16,181,157 shares of the company’s stock valued at $38,673,000 after buying an additional 3,681,157 shares during the period. Mirae Asset Global Investments Co. Ltd. increased its position in Tilray by 2.9% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 2,465,698 shares of the company’s stock valued at $5,671,000 after purchasing an additional 70,482 shares during the period. Public Sector Pension Investment Board raised its holdings in Tilray by 11.4% during the 3rd quarter. Public Sector Pension Investment Board now owns 1,519,415 shares of the company’s stock worth $3,630,000 after purchasing an additional 155,672 shares during the last quarter. Swiss National Bank lifted its position in shares of Tilray by 1.7% in the 3rd quarter. Swiss National Bank now owns 1,456,738 shares of the company’s stock worth $3,482,000 after purchasing an additional 24,800 shares during the period. Finally, TD Asset Management Inc boosted its stake in shares of Tilray by 5.6% in the 3rd quarter. TD Asset Management Inc now owns 1,204,434 shares of the company’s stock valued at $2,877,000 after purchasing an additional 64,300 shares during the last quarter. 9.35% of the stock is owned by institutional investors.

Tilray Stock Up 1.7 %

Shares of NASDAQ TLRY opened at $1.78 on Friday. Tilray Inc has a 12-month low of $1.50 and a 12-month high of $3.40. The company has a quick ratio of 1.18, a current ratio of 1.92 and a debt-to-equity ratio of 0.11. The firm has a market cap of $1.38 billion, a PE ratio of -4.05 and a beta of 2.36. The company’s fifty day simple moving average is $1.95 and its 200 day simple moving average is $1.94.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on TLRY. Alliance Global Partners lifted their target price on shares of Tilray from $2.25 to $2.75 and gave the stock a “neutral” rating in a research note on Friday, April 5th. CIBC dropped their price objective on Tilray from $2.25 to $2.00 and set a “neutral” rating on the stock in a research note on Wednesday, April 10th. Finally, Canaccord Genuity Group cut their target price on Tilray from $4.25 to $4.00 and set a “buy” rating on the stock in a research report on Wednesday, April 10th.

Tilray Company Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.